Saturday, May 30, 2020
Home Tags Drug development

Tag: drug development

Black Swan: rare Jamaican cannabis strain could treat pancreatic cancer

Black Swan: rare Jamaican cannabis strain could treat pancreatic cancer

In 2019 a flavonoid of cannabis – Caflanone (FBL-03G) – was granted Orphan drug status by the United States Food and Drug Administration. Now,...
Clinical trials: FDA marks psilocybin for depression treatment

Clinical trials: FDA marks psilocybin for depression treatment

The FDA designation represents a major step forward in mental health research and for patients suffering from depression. A non-profit medical research centre, the Usona...
Artificial Intelligence can design new TB drug regimens

Artificial Intelligence can design new TB drug regimens

Despite the availability of TB vaccines, 1.5 million people died from TB in 2018. With a shortage of new tuberculosis drugs in the pipeline, a...
Scientus Pharma: solving drug development challenges for cannabinoid-based drugs

Scientus Pharma: solving drug development challenges for cannabinoid-based drugs

Scientus Pharma have already uncovered areas of remarkable potential with a focus on practical applications, could drug development challenges be solved? Here, we learn how...
Call for patients to take part in anorexia psilocybin treatment study

Scientists undertake anorexia psilocybin treatment study

A new wave of scientific research looking at psilocybin could offer promise for the treatment of a number of mental and medical conditions –...
Clinical trials anticipated for treating pancreatic cancer with cannabis

Clinical trials anticipated for treating pancreatic cancer with cannabis

A flavonoid of cannabis – FBL-03G – has been granted Orphan drug status by the United States Food and Drug Administration. It is anticipated this...
Structure of a novel enzyme linked to cell growth and cancer cracked

Structure of a novel enzyme linked to cell growth and cancer cracked

A new UC Riverside-led study could lead to the development of drugs that target liver and other cancers. RNA, or ribonucleic acid, is present in...
Tetra Bio-Pharma: global developer of cannabinoid-derived products

Tetra Bio-Pharma: global developer of cannabinoid-derived products

Dr Guy Chamberland explains how Tetra Bio-Pharma is taking a pharmaceutical pathway to discovering and developing cannabinoid-derived products. In an industry that could aptly be...

More efficient drug delivery within the brain by utilising LAT1

According to a new study carried out at the University of Eastern Finland, drug delivery within the brain can be improved by utilising LAT1,...

Study reveals promising alternative for HIV daily pill regimen

A new study has shown that a long-acting injectable multi-drug implant could offer promise as an alternative for HIV prevention and treatment. Published in Nature...
Scorpion toxin targeting 'wasabi receptor' could help solve mystery of chronic pain

Scorpion toxin targeting ‘wasabi receptor’ could help solve mystery of chronic pain

Researchers found a scorpion toxin targeting the 'wasabi receptor', a chemical-sensing protein located in nerve cells responsible for the sinus-jolting sting of wasabi. At UC...
How pre-filled syringes are helping to deliver the personalised drug revolution

How pre-filled syringes are helping to deliver the personalised drug revolution

With ‘novel’ biologic and personalised drugs being used to treat and cure chronic ailments, discover how pre-filled syringes are set to gain high traction...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest